International Biotechnology Trust (IBT)

Category Sector Equity Biotechnology

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.

Sell

980.00p

Buy

992.00p

arrow-up16.00p (+1.64%)

Discount/Premium

-6.00%

Estimated NAV

1,053.228p

Prices updated at 12 Dec 2025, 16:43 GMT

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

	974.00
Launch date	06 May 1994
	996.00p - 968.00p
	996.00p - 480.00p
	1,039.80 as of 10 Dec 2025
Ongoing charge audited (%)	1.3
	1.5
	0.06
	2.66
	111,176.96
	31.90m
	315.84m
	98.41
	Semi-Annually
	£336.01m
	£340.79m
	-9.69
	-9.62
	-8.67
Fund comparative index	Nasdaq Biotechnology Index
	Daily
	0.10m
	0.72m
	GB0004559349

Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.